Reuters logo
2 个月前
BRIEF-Myovant Sciences announces presentation of data at the European congress of endocrinology
2017年5月24日 / 中午12点08分 / 2 个月前

BRIEF-Myovant Sciences announces presentation of data at the European congress of endocrinology

1 分钟阅读

May 24 (Reuters) - Myovant Sciences Ltd:

* Myovant Sciences announces presentation of data at the european congress of endocrinology from phase 2 extension study evaluating relugolix in women with endometriosis-associated pain

* Myovant Sciences- treatment-emergent adverse events for patients receiving relugolix, such as hot flush & menorrhagia, were consistent with drug's mechanism of action Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below